Baidu
map

JCLA:通过重组酶-聚合酶扩增- sybr green I法肉眼检测结核分枝杆菌复合物

2019-06-03 不详 网络

结核分枝杆菌(Mtb)的快速诊断是控制结核病传播的关键,也是全球健康问题。本研究利用等温重组酶聚合酶扩增(RPA)技术检测了Mtb、IS6110和IS1081的特异性靶点。此外,使用肉眼检测了SYBR Green I的RPA产物。 研究人员利用RPA分别在IS6110和IS1081位点扩增了146份基因组Mtb DNA和24份基因组非结核分枝杆菌(NTM) DNA。完成扩增后,用琼脂糖凝胶电

结核分枝杆菌(Mtb)的快速诊断是控制结核病传播的关键,也是全球健康问题。本研究利用等温重组酶聚合酶扩增(RPA)技术检测了MtbIS6110IS1081的特异性靶点。此外,使用肉眼检测了SYBR Green IRPA产物。

研究人员利用RPA分别在IS6110IS1081位点扩增了146份基因组Mtb DNA24份基因组非结核分枝杆菌(NTM) DNA。完成扩增后,用琼脂糖凝胶电泳(RPAAGE)SYBR Green I (RPAS)检测RPA扩增子。通过与传统PCR方法的比较,评价了RPA法的性能。

结果表明,RPA法在恒温条件下具有较好的鉴别MtbNTM的能力,且在很短的时间内就能鉴别出MtbNTM。与传统PCR方法相比,RPA‐年龄对IS6110IS1081的敏感性和特异性均为100%RPAS对两种靶点的特异性均为100%;但对IS6110IS1081的敏感性分别为97.95%99.32%IS6110 RPA‐年龄和RPAS的检测限分别为0.050.5 ng,而IS1081 RPA‐年龄和RPASLODs分别为0.000050.05 ng。两种RPA检测均显示出令人满意的诊断特异性,与其他细菌无交叉反应。

研究表明,这种快速、灵敏、裸眼RPA检测方法可以集成到Mtb检测的定点护理诊断中,特别是在实验室仪器资源有限的偏远地区。

原始出处:

Nuntita Singpanomchai, Yukihiro Akeda ,Naked eye detection of the Mycobacterium tuberculosis complex by recombinase polymerase amplificationSYBR green I assays

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1910637, encodeId=4b3e191063ed6, content=<a href='/topic/show?id=b45b426195e' target=_blank style='color:#2F92EE;'>#复合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42619, encryptionId=b45b426195e, topicName=复合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad7f282, createdName=yang0210, createdTime=Thu Aug 22 06:34:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955988, encodeId=5629195598840, content=<a href='/topic/show?id=30ac80810c0' target=_blank style='color:#2F92EE;'>#聚合酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80810, encryptionId=30ac80810c0, topicName=聚合酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5712500001, createdName=晓辰, createdTime=Mon Nov 11 11:34:00 CST 2019, time=2019-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942704, encodeId=ed9e1942e0419, content=<a href='/topic/show?id=42a831e76af' target=_blank style='color:#2F92EE;'>#分枝杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31776, encryptionId=42a831e76af, topicName=分枝杆菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sun Jun 30 07:34:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254284, encodeId=496b12542844a, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Jun 05 13:34:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439755, encodeId=942f1439e55d0, content=<a href='/topic/show?id=89d9e86326c' target=_blank style='color:#2F92EE;'>#结核分枝杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78632, encryptionId=89d9e86326c, topicName=结核分枝杆菌)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Jun 05 13:34:00 CST 2019, time=2019-06-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1910637, encodeId=4b3e191063ed6, content=<a href='/topic/show?id=b45b426195e' target=_blank style='color:#2F92EE;'>#复合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42619, encryptionId=b45b426195e, topicName=复合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad7f282, createdName=yang0210, createdTime=Thu Aug 22 06:34:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955988, encodeId=5629195598840, content=<a href='/topic/show?id=30ac80810c0' target=_blank style='color:#2F92EE;'>#聚合酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80810, encryptionId=30ac80810c0, topicName=聚合酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5712500001, createdName=晓辰, createdTime=Mon Nov 11 11:34:00 CST 2019, time=2019-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942704, encodeId=ed9e1942e0419, content=<a href='/topic/show?id=42a831e76af' target=_blank style='color:#2F92EE;'>#分枝杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31776, encryptionId=42a831e76af, topicName=分枝杆菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sun Jun 30 07:34:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254284, encodeId=496b12542844a, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Jun 05 13:34:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439755, encodeId=942f1439e55d0, content=<a href='/topic/show?id=89d9e86326c' target=_blank style='color:#2F92EE;'>#结核分枝杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78632, encryptionId=89d9e86326c, topicName=结核分枝杆菌)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Jun 05 13:34:00 CST 2019, time=2019-06-05, status=1, ipAttribution=)]
    2019-11-11 晓辰
  3. [GetPortalCommentsPageByObjectIdResponse(id=1910637, encodeId=4b3e191063ed6, content=<a href='/topic/show?id=b45b426195e' target=_blank style='color:#2F92EE;'>#复合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42619, encryptionId=b45b426195e, topicName=复合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad7f282, createdName=yang0210, createdTime=Thu Aug 22 06:34:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955988, encodeId=5629195598840, content=<a href='/topic/show?id=30ac80810c0' target=_blank style='color:#2F92EE;'>#聚合酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80810, encryptionId=30ac80810c0, topicName=聚合酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5712500001, createdName=晓辰, createdTime=Mon Nov 11 11:34:00 CST 2019, time=2019-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942704, encodeId=ed9e1942e0419, content=<a href='/topic/show?id=42a831e76af' target=_blank style='color:#2F92EE;'>#分枝杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31776, encryptionId=42a831e76af, topicName=分枝杆菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sun Jun 30 07:34:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254284, encodeId=496b12542844a, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Jun 05 13:34:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439755, encodeId=942f1439e55d0, content=<a href='/topic/show?id=89d9e86326c' target=_blank style='color:#2F92EE;'>#结核分枝杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78632, encryptionId=89d9e86326c, topicName=结核分枝杆菌)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Jun 05 13:34:00 CST 2019, time=2019-06-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1910637, encodeId=4b3e191063ed6, content=<a href='/topic/show?id=b45b426195e' target=_blank style='color:#2F92EE;'>#复合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42619, encryptionId=b45b426195e, topicName=复合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad7f282, createdName=yang0210, createdTime=Thu Aug 22 06:34:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955988, encodeId=5629195598840, content=<a href='/topic/show?id=30ac80810c0' target=_blank style='color:#2F92EE;'>#聚合酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80810, encryptionId=30ac80810c0, topicName=聚合酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5712500001, createdName=晓辰, createdTime=Mon Nov 11 11:34:00 CST 2019, time=2019-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942704, encodeId=ed9e1942e0419, content=<a href='/topic/show?id=42a831e76af' target=_blank style='color:#2F92EE;'>#分枝杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31776, encryptionId=42a831e76af, topicName=分枝杆菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sun Jun 30 07:34:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254284, encodeId=496b12542844a, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Jun 05 13:34:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439755, encodeId=942f1439e55d0, content=<a href='/topic/show?id=89d9e86326c' target=_blank style='color:#2F92EE;'>#结核分枝杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78632, encryptionId=89d9e86326c, topicName=结核分枝杆菌)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Jun 05 13:34:00 CST 2019, time=2019-06-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1910637, encodeId=4b3e191063ed6, content=<a href='/topic/show?id=b45b426195e' target=_blank style='color:#2F92EE;'>#复合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42619, encryptionId=b45b426195e, topicName=复合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad7f282, createdName=yang0210, createdTime=Thu Aug 22 06:34:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955988, encodeId=5629195598840, content=<a href='/topic/show?id=30ac80810c0' target=_blank style='color:#2F92EE;'>#聚合酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80810, encryptionId=30ac80810c0, topicName=聚合酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5712500001, createdName=晓辰, createdTime=Mon Nov 11 11:34:00 CST 2019, time=2019-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942704, encodeId=ed9e1942e0419, content=<a href='/topic/show?id=42a831e76af' target=_blank style='color:#2F92EE;'>#分枝杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31776, encryptionId=42a831e76af, topicName=分枝杆菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sun Jun 30 07:34:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1254284, encodeId=496b12542844a, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Jun 05 13:34:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439755, encodeId=942f1439e55d0, content=<a href='/topic/show?id=89d9e86326c' target=_blank style='color:#2F92EE;'>#结核分枝杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78632, encryptionId=89d9e86326c, topicName=结核分枝杆菌)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Jun 05 13:34:00 CST 2019, time=2019-06-05, status=1, ipAttribution=)]

相关资讯

JCLA:10年前韩国结核分枝杆菌的分布

结核(TB)是由结核分枝杆菌(MTB)所引起的传染病。该疾病通过空气在人际间传播。本研究的目的是通过收集和分析韩国标本数据来评估结核病的流行情况及其临床趋势。 在2005年9月至2016年6月所有临床标本在韩国天安市的Dankook大学医院实验室进行了测试,使用固体和液体培养物,抗酸杆菌(AFB)涂片和聚合酶链式反应(PCR)分离MTB。 本研究总共收集146150个标本; 平均TB阳

Science:重磅:南开大学饶子和院士团队破解结核分枝杆菌能量代谢奥秘,助力抗结核新药研发

美国东部时间10月25日下午,该成果论文以研究长文的形式在线发表于国际顶级学术期刊《科学》(Science)上。北京时间26日下午,饶子和院士在南开大学省身楼举办的发布会上介绍了这一重大科学进展。

探案:反复咯血1年余,会是感染病吗?

患者自2年前无明显诱因下开始出现咳嗽、咳泡沫样痰,否认发热、咯血、盗汗等不适,曾至上海某三甲医院就诊,当时查胸部CT示两肺散在斑片阴影,外院考虑为支气管扩张伴感染,予左氧氟沙星、头孢曲松抗感染治疗2周,后咳嗽咳痰较前好转,予以停药。

JCLA:检测结核分枝杆菌RT-LAMP和LAMP法的评估

目前用于检测结核分枝杆菌(Mtb)的方法在临床上并不是最优化的。其中,标准培养方法(SCM)速度慢,成本昂贵且可能不可靠,而环介导的等温扩增(LAMP)不能区分活Mtb。 该研究比较了用于检测Mtb的几种方法,包括逆转录(RT)-LAMP,LAMP和SCM。对9种的结核分枝杆菌(H37Rv,胞内分枝杆菌,海分枝杆菌,堪萨斯分枝杆菌,鸟分枝杆菌,M.苦参,耻垢分枝杆菌,偶发分枝杆菌,和龟分枝杆菌)

结核分枝杆菌复合体的生态和进化

过去 200 年,有 10 亿人因结核病(TB)而死亡。 直到今天,结核病仍然是造成死亡人数最多的传染病,WTO 估计每年有 1040 万新发结核病患者,每年有 170 万人因结核病而死亡。此外,研究人员估计全球四分之一的人已经被结核菌潜伏感染,从而成为潜在活动性结核病患者。

Baidu
map
Baidu
map
Baidu
map